| Price | $1.91 |
| Year Range | $1.91 – $1.91 |
| Market Cap | $59M |
| Industry | Biotechnology |
What Is DURECT’s AI Stock Analysis?
DURECT’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks DURECT’s momentum in near-real time.
DURECT (DRRX) has an AltIndex AI Score of 47/100, currently a Hold signal. The AI Score distills DURECT's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
DURECT’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of DURECT — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving DRRX’s AI Score?
Fundamentals
Revenue for the last quarter was $450,000. This is an increase of 39.25% compared to the quarter before it, which is a positive sign of growth. However, compared to the same quarter last year, there is a decrease of 79.41%, which may be a cause for concern. Net income for the last quarter was $-2.3M. This is an increase of -46.48% compared to the quarter before it, which is a positive sign of growth. Compared to the same quarter last year, there is an increase of -38.78%, suggesting positive year-over-year growth. Ebitda for the last quarter was $-2.3M. This is an increase of -44.35% compared to the quarter before it, which is a positive sign of growth. Compared to the same quarter last year, there is an increase of -30.41%, suggesting positive year-over-year growth.
See DURECT’s earnings and insider transactions.
Technicals
Today's stock price is $1.91. This is equal to the stock price a month ago, showing short-term stability. However, compared to a year ago, there is a decrease of 2.55%, which could be a cause for long-term concern. The trend is neutral. The current SMA10 of $1.91 is equal to the previous SMA10, indicating no significant change in the trend. The RSI is 0, indicating a potentially oversold (bullish) condition.
See the full technical analysis and price prediction.
Alternative data
DURECT has an estimate of 0 visitors to their webpage. The number of visitors is down by -100% in the last couple of months, a worrisome trend as this can indicate a loss in customers.
Explore DURECT’s job postings, web traffic and app downloads.
Sentiment & social
The sentiment for the stock on various stock forums is very high, a positive sign. DURECT has 360 followers on their Twitter page, with no meaningful increase or decrese in the last couple of months.
Track DURECT’s market sentiment.
Frequently Asked Questions: DURECT AI Stock Analysis
DURECT's AltIndex AI Score is 47/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates DURECT a Hold (47/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of DURECT — company overview, fundamentals, technicals and alternative data, with a recommendation. See the DRRX AI Score or sign up to read the full thesis.
